These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10837936

  • 1. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?
    Freeman CR, Kepner J, Kun LE, Sanford RA, Kadota R, Mandell L, Friedman H.
    Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):561-4. PubMed ID: 10837936
    [Abstract] [Full Text] [Related]

  • 2. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.
    Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, Kovnar E, Burger P, Sanford RA, Kepner J, Friedman H, Kun LE.
    Int J Radiat Oncol Biol Phys; 1999 Mar 15; 43(5):959-64. PubMed ID: 10192340
    [Abstract] [Full Text] [Related]

  • 3. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1182-5. PubMed ID: 12654425
    [Abstract] [Full Text] [Related]

  • 4. Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833.
    Kretschmar CS, Tarbell NJ, Barnes PD, Krischer JP, Burger PC, Kun L.
    Cancer; 1993 Aug 15; 72(4):1404-13. PubMed ID: 8339231
    [Abstract] [Full Text] [Related]

  • 5. Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group.
    Freeman CR, Bourgouin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE.
    Cancer; 1996 Feb 01; 77(3):555-62. PubMed ID: 8630965
    [Abstract] [Full Text] [Related]

  • 6. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J, Siffert J, Donahue B, Nirenberg A, Jakacki R, Robertson P, DaRosso R, Thoron L, Rosovsky M, Pinto R.
    Cancer; 1999 Sep 15; 86(6):1064-9. PubMed ID: 10491535
    [Abstract] [Full Text] [Related]

  • 7. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
    Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):227-30. PubMed ID: 17278121
    [Abstract] [Full Text] [Related]

  • 8. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study.
    Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, Halperin EC, Munoz L, Friedman HS, Kun LE.
    Int J Radiat Oncol Biol Phys; 1993 Sep 30; 27(2):197-206. PubMed ID: 8407392
    [Abstract] [Full Text] [Related]

  • 9. UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group.
    Lewis J, Lucraft H, Gholkar A.
    Int J Radiat Oncol Biol Phys; 1997 Jul 15; 38(5):925-9. PubMed ID: 9276356
    [Abstract] [Full Text] [Related]

  • 10. Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy.
    Jennings MT, Freeman ML, Murray MJ.
    J Neurooncol; 1996 Jul 15; 28(2-3):207-22. PubMed ID: 8832463
    [Abstract] [Full Text] [Related]

  • 11. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.
    Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, Selch MT, Cherlow JM, Finlay JL, Wara WM.
    Cancer; 1994 Sep 15; 74(6):1827-34. PubMed ID: 8082086
    [Abstract] [Full Text] [Related]

  • 12. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A, Sarin R, Kurkure P.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):113-8. PubMed ID: 19647954
    [Abstract] [Full Text] [Related]

  • 13. Diffuse brain stem gliomas. Are we improving outcome?
    Shuper A, Kornreich L, Loven D, Michowitz S, Schwartz M, Cohen IJ.
    Childs Nerv Syst; 1998 Oct 01; 14(10):578-81. PubMed ID: 9840382
    [Abstract] [Full Text] [Related]

  • 14. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE, Tsujii H, Hasegawa A, Yanagi T, Takagi R, Kamada T, Tsuji H, Takakura K, Organizing Committee of the Central Nervous System Tumor Working Group.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):390-6. PubMed ID: 17459607
    [Abstract] [Full Text] [Related]

  • 15. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma.
    Kleinberg L, Grossman SA, Piantadosi S, Zeltzman M, Wharam M.
    Int J Radiat Oncol Biol Phys; 1999 Jun 01; 44(3):535-43. PubMed ID: 10348282
    [Abstract] [Full Text] [Related]

  • 16. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.
    Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, Luporsi E, Margueritte G, Lejars O, Laithier V, Mechinaud F, Millot F, Kalifa C, Chastagner P.
    Cancer; 2005 Dec 15; 104(12):2792-7. PubMed ID: 16265674
    [Abstract] [Full Text] [Related]

  • 17. [Concomitant chemoradiotherapy and malignant glial tumors in the adult].
    Honnorat J.
    Cancer Radiother; 1998 Dec 15; 2(6):672-8. PubMed ID: 9922772
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA, Lamborn K, Wara W, Davis R, Edwards M, Rabbitt J, Malec M, Prados MD.
    Neuro Oncol; 2000 Jan 15; 2(1):22-8. PubMed ID: 11302250
    [Abstract] [Full Text] [Related]

  • 19. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y.
    Cancer; 1983 Sep 15; 52(6):997-1007. PubMed ID: 6349785
    [Abstract] [Full Text] [Related]

  • 20. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
    Walter AW, Gajjar A, Ochs JS, Langston JW, Sanford RA, Kun LE, Heideman R.
    Med Pediatr Oncol; 1998 Jan 15; 30(1):28-33. PubMed ID: 9371386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.